Clinical Trials on Ichthyosis, Lamellar in New Zealand
Total 44 results
-
Northwestern UniversityIcahn School of Medicine at Mount SinaiCompletedNetherton Syndrome | Ichthyosis | Lamellar Ichthyosis | Autosomal Recessive Congenital Ichthyosis | Congenital Ichthyosiform Erythroderma | Epidermolytic IchthyosisUnited States
-
Mayne Pharma International Pty LtdTerminatedLamellar IchthyosisUnited States, Spain, Canada, Germany, France, Australia, Israel, Ukraine, United Kingdom
-
Yale UniversityFoundation for Ichthyosis & Related Skin Types (FIRST)TerminatedIchthyosisUnited States
-
Timber Pharmceuticals LLCCompletedCongenital IchthyosisUnited States, Australia
-
Patagonia Pharmaceuticals, LLCCompletedCongenital IchthyosisUnited States
-
Crown Laboratories, Inc.CompletedIchthyosis VulgarisUnited States
-
AnaptysBio, Inc.Terminated
-
Northwestern UniversityIcahn School of Medicine at Mount Sinai; Galderma R&DRecruiting
-
Timber Pharmaceuticals Inc.Active, not recruitingIchthyosisUnited States, Canada, Germany, France, Italy
-
Galderma R&DCompletedGlabellar Frown Lines | Canthal LinesUnited States
-
AllerganCompletedGlabellar LinesUnited States
-
Medy-ToxCompletedGlabellar LinesUnited States, Belgium, Russian Federation
-
Medy-ToxCompletedGlabellar Frown LinesAustralia
-
Revance Therapeutics, Inc.CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesGlabellar Frown LinesUnited States
-
Galderma R&DCompletedGlabellar Frown LinesUnited States
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States
-
Galderma R&DCompletedWrinkles | Glabellar LinesUnited States
-
Galderma R&DCompletedGlabellar Frown LinesUnited States, Canada
-
Serene Medical IncCompleted
-
Medy-ToxCompletedLateral Canthal Lines | Glabellar LinesUnited States, Germany, Canada
-
AllerganCompletedGlabellar LinesUnited States, Puerto Rico
-
Merz Pharmaceuticals GmbHCompletedGlabellar LinesUnited States, Germany, Canada
-
AllerganCompleted
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesUnited States, Canada
-
Medy-ToxCompletedLateral Canthal Lines | Glabellar LinesUnited States, Germany, Canada, United Kingdom
-
Revance Therapeutics, Inc.CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesGlabellar Frown LinesUnited States, Canada
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedPruritus | IchthyosisUnited States
-
NYU Langone HealthCompletedPatellar Femoral SyndromeUnited States
-
Medy-ToxCompletedLateral Canthal Lines | Glabellar LinesUnited States, Russian Federation, Germany, Canada, Belgium, United Kingdom
-
AllerganCompletedGlabellar LinesUnited States, Canada, Germany, Hungary, Poland
-
State University of New York at BuffaloCarestream Health, Inc.CompletedPatellar (or Kneecap) Instability and Mal-alignmentUnited States
-
Galderma R&DCompletedGlabellar Frown Lines (GL) | Lateral Canthal Lines (LCL)United States, Canada
-
Galderma R&DCompletedLateral Canthal Lines | Glabellar LinesUnited States, Puerto Rico
-
Columbia UniversityNot yet recruiting
-
Merz North America, Inc.Completed
-
Azitra Inc.Not yet recruiting
-
AllerganCompletedFacial Rhytides | Glabellar RhytidesUnited States, Belgium, Germany, United Kingdom
-
Boehringer IngelheimRecruitingNetherton SyndromeBelgium, United Kingdom, Australia, Germany, China, Malaysia, Japan, France, United States, Israel, Bulgaria, Italy, Switzerland, Austria, Netherlands, Portugal
-
Revance Therapeutics, Inc.CompletedUpper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)United States, Canada
-
Novartis PharmaceuticalsCompletedHealthy Volunteers | Atopic Dermatitis | Netherton SyndromeNetherlands, United States
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)United States
-
Applied GeneticsUnknownPrecancerous ConditionUnited States, Germany, United Kingdom
-
Aldeyra Therapeutics, Inc.CompletedSjogren-Larsson SyndromeUnited States
-
Translational Research Center for Medical Innovation...RecruitingNeutral Lipid Storage DiseaseChina, United States, France, Austria, Germany, Italy, Japan, Netherlands, United Kingdom